 |
Flexion Therapeutics, Inc.
FLXN
|
1.49 B |
- |
- |
$ 459 M |
USA |
 |
Heat Biologics, Inc.
HTBX
|
4.26 B |
- |
-5.76 % |
$ 99.8 M |
USA |
 |
Kindred Biosciences, Inc.
KIN
|
20.2 B |
- |
0.11 % |
$ 419 M |
USA |
 |
Shineco, Inc.
TYHT
|
22.9 B |
- |
-3.90 % |
$ 97.2 M |
China |
 |
Millendo Therapeutics, Inc.
MLND
|
31.7 B |
- |
-5.36 % |
$ 20.2 M |
USA |
 |
Intec Pharma Ltd
NTEC
|
2.88 B |
- |
-12.45 % |
$ 17.7 M |
Israel |
 |
Progenity, Inc.
PROG
|
225 M |
- |
-3.47 % |
$ 164 M |
USA |
 |
Strongbridge Biopharma plc
SBBP
|
32.8 B |
- |
1.52 % |
$ 136 M |
USA |
 |
Seneca Biopharma, Inc.
SNCA
|
2.82 B |
- |
-1.19 % |
$ 28.7 M |
USA |
 |
Celsion Corporation
CLSN
|
-3.55 M |
- |
-6.63 % |
$ 13.9 M |
USA |
 |
I-Mab
IMAB
|
127 M |
- |
- |
$ 866 M |
China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
1.95 B |
- |
- |
$ 40.3 B |
USA |
 |
Genfit SA
GNFT
|
168 B |
- |
2.54 % |
$ 160 B |
France |
 |
Biophytis SA
BPTS
|
174 M |
- |
-13.47 % |
$ 169 M |
France |
 |
CureVac N.V.
CVAC
|
-376 M |
- |
- |
$ 867 M |
Germany |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
686 M |
- |
0.74 % |
$ 768 M |
Israel |
 |
Abcam plc
ABCM
|
5.18 B |
- |
- |
$ 4.9 B |
Britain |
 |
Midatech Pharma plc
MTP
|
-1.76 M |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
MorphoSys AG
MOR
|
2.44 B |
- |
2.43 % |
$ 254 M |
Germany |
 |
Affimed N.V.
AFMD
|
-38.5 M |
- |
-34.95 % |
$ 21.5 M |
Germany |
 |
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
215 M |
- |
-1.58 % |
$ 28.1 M |
China |
 |
Celyad Oncology SA
CYAD
|
-1.83 M |
- |
- |
$ 12.5 M |
Belgium |
 |
Gracell Biotechnologies
GRCL
|
-1.17 B |
- |
- |
$ 3.37 B |
China |
 |
Galapagos NV
GLPG
|
1.99 B |
- |
- |
$ 1.83 B |
Belgium |
 |
Teligent, Inc.
TLGT
|
4.75 B |
- |
-13.85 % |
$ 16.1 M |
USA |
 |
Viela Bio, Inc.
VIE
|
5.37 B |
- |
- |
$ 2.91 B |
USA |
 |
Aphria Inc.
APHA
|
54.3 B |
- |
-0.45 % |
$ 4.87 B |
Canada |
 |
Aerpio Pharmaceuticals, Inc.
ARPO
|
3.74 B |
- |
-0.90 % |
$ 104 M |
USA |
 |
Chiasma, Inc.
CHMA
|
19.2 B |
- |
-6.00 % |
$ 238 M |
USA |
 |
Adamas Pharmaceuticals, Inc.
ADMS
|
-10.8 M |
- |
- |
$ 376 M |
USA |
 |
Cellect Biotechnology Ltd.
APOP
|
1.09 B |
- |
0.38 % |
$ 12.9 M |
Israel |
 |
AzurRx BioPharma, Inc.
AZRX
|
864 M |
- |
2.07 % |
$ 34.4 M |
USA |
 |
Cerecor Inc.
CERC
|
2.9 B |
- |
-1.68 % |
$ 283 M |
USA |
 |
Constellation Pharmaceuticals, Inc.
CNST
|
-2.87 M |
- |
- |
$ 1.63 B |
USA |
 |
Auris Medical Holding Ltd.
EARS
|
1.5 B |
- |
-1.77 % |
$ 39.2 M |
Bermuda |
 |
Dicerna Pharmaceuticals, Inc.
DRNA
|
80.3 M |
- |
0.34 % |
$ 2.98 B |
USA |
 |
ERYTECH Pharma S.A.
ERYP
|
-14.6 M |
- |
1.3 % |
$ 27.7 M |
France |
 |
GW Pharmaceuticals plc
GWPH
|
33.2 M |
- |
- |
$ 6.81 B |
Britain |
 |
Kadmon Holdings, Inc.
KDMN
|
27.5 B |
- |
- |
$ 1.7 B |
USA |
 |
Liminal BioSciences
LMNL
|
-22.9 M |
- |
- |
$ 256 M |
Canada |
 |
Neos Therapeutics, Inc.
NEOS
|
-14.1 M |
- |
-2.54 % |
$ 57.2 M |
USA |
 |
Odonate Therapeutics, Inc.
ODT
|
5.24 B |
- |
-3.18 % |
$ 58.5 M |
USA |
 |
Orphazyme A/S
ORPH
|
284 M |
- |
-2.25 % |
$ 31.3 M |
Danmark |
 |
Osmotica Pharmaceuticals plc
OSMT
|
6.61 B |
- |
-10.74 % |
$ 89.9 M |
USA |
 |
Pandion Therapeutics, Inc.
PAND
|
29.5 K |
- |
- |
$ 1.77 B |
USA |
 |
Translate Bio, Inc.
TBIO
|
1.43 B |
- |
- |
$ 2.81 B |
USA |
 |
Trillium Therapeutics Inc.
TRIL
|
83.6 M |
- |
- |
$ 1.94 B |
Canada |
 |
Urovant Sciences Ltd.
UROV
|
37.4 B |
- |
- |
$ 532 M |
Britain |
 |
Acceleron Pharma Inc.
XLRN
|
-182 M |
- |
- |
$ 10.9 B |
USA |